Sun Pharma
Search results
The product now launched heralds a breakthrough in affordability and cure for millions. At Natco we manufacture niche and complex Pharma products under the pressure of expectation. The need of society creates a global demand for affordable drugs, which we are focused on meeting.
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
5 days ago · Also read: Natco Pharma invests $2 million in Cellogen Therapeutics As the company is strong in oncology, it might augur well for its business going forward. “We feel that a lot of the oncology ...
Share Price: - The current share price of Natco Pharma is Rs 1166.85. One can use valuation calculators of ticker to know if Natco Pharma share price is undervalued or overvalued.
Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations.
Oct 20, 2023 · Drugmaker Natco Pharma has received eight observations following a U.S. Food and Drug Administration inspection of the company’s pharma division in Kothur, Hyderabad.
2 days ago · Natco Pharma Ltd. has declared 34 dividends since 10 Nov 2005. At the current share price of ₹1198.95, Natco Pharma Ltd.'s dividend yield is 0.10%. Ex-Date. Dividend amount. Dividend type. Record Date. Instrument type. 26 Feb 2024. 1.25.
Natco Pharma Ltd. is an India-based company engaged in manufacturing active pharmaceutical ingredients.The Company's segments include bulk chemicals, finished dosage formulations, retail...
Mar 15, 2021 · Natco will launch the Pheromone product, for management of Pink Bollworm, under the brand Natmate PBW. This is the first pheromone-based indigenously manufactured product for mating disruption ...
Mar 4, 2013 · The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market...
